Malignant pertussis in infants: 4 new cases in French Guiana

Cédric Ngila Lubunu1, Christelle Samou-Fontcho1, Urbain Agbessy Awanou1

  • 1Service de pédiatrie, CHU de Guyane, site de Cayenne, 3 avenue Alexis Blaise, Cayenne 97300, French Guiana; Service de pédiatrie, CHU de Guyane, site de Saint-Laurent-du-Maroni, Avenue Paul Castaing, Saint-Laurent du Maroni 97320, French Guiana; Service de médecine et réanimation néonatale, CHU de Guyane, 3 avenue Alexis Blaise, Cayenne 97300, French Guiana.

Insights

Malignant pertussis is a severe condition in infants, causing respiratory failure and high mortality. Vaccination is crucial for preventing these dangerous cases and protecting vulnerable populations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Malignant pertussis is a severe form of pertussis.
  • It is characterized by respiratory distress, polyvisceral failure, and marked hyperlymphocytosis.
  • Typical presentations include profound leukocytosis, pulmonary hypertension, and respiratory failure.

Purpose of the Study:

  • To report on four cases of malignant pertussis in young infants.
  • To highlight the severity and outcomes of this condition.
  • To emphasize the importance of vaccination in preventing severe pertussis.

Main Methods:

  • Case series reporting on four infants with malignant pertussis.
  • Clinical data including presentation, treatment, and outcomes were reviewed.
  • One patient received exchange transfusion.

Main Results:

  • The case fatality rate in the reported cases was 50%.
  • Malignant pertussis presented with severe symptoms including respiratory failure and hyperlymphocytosis.
  • The condition is associated with high mortality and significant intensive care costs.

Conclusions:

  • Malignant pertussis is a severe and often fatal condition in infants.
  • Vaccination is the primary strategy for preventing these severe cases.
  • Ensuring infant immunization and extending it to at-risk adults is essential to prevent transmission.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
901
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K